Reverie Labs Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.4M

Reverie Labs General Information

Description

Operator of a drug development platform intended to improve the drug design pipeline. The company's platform uses state-of-the-art machine learning methods to screen massive libraries of small molecules and identify potential drug candidates, enabling pharmaceutical companies to run each company's novel crystal structures through their technology and identify small molecules.

Contact Information

Website
www.reverielabs.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 675 Massachusetts Avenue
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Ginkgo Bioworks
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 675 Massachusetts Avenue
  • Cambridge, MA 02139
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reverie Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 23-Feb-2024 $2.4M Completed Generating Revenue
4. Early Stage VC (Series A1) 03-Feb-2021 Completed Generating Revenue
3. Accelerator/Incubator 19-Mar-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Mar-2018 $6.5M $6.51M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2017 $5K $5K Completed Startup
To view Reverie Labs’s complete valuation and funding history, request access »

Reverie Labs Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A-4
Series A-3 2,798,775 $0.000100 8% $0.82 $0.82 1x $0.82 7.75%
Series A-2 2,859,765 $0.000100 8% $1.36 $1.36 1x $1.36 7.92%
To view Reverie Labs’s complete cap table history, request access »

Reverie Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug development platform intended to improve the drug design pipeline. The company's platform uses state-
Drug Discovery
Cambridge, MA
13 As of 2024

Dallas, TX
 

Kobe, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Reverie Labs Competitors (3)

One of Reverie Labs’s 3 competitors is AROG Pharmaceuticals, a Corporation company based in Dallas, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AROG Pharmaceuticals Corporation Dallas, TX
Carna Biosciences Formerly VC-backed Kobe, Japan
NexImmune Formerly VC-backed Gaithersburg, MD
You’re viewing 3 of 3 competitors. Get the full list »

Reverie Labs Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Reverie Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240383875-A1 Benzimidazole pyridine derivatives Pending 19-Jan-2022
US-20220281863-A1 Compounds, compositions and methods of treating disorders Pending 22-Nov-2019

Reverie Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reverie Labs Former Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
BoxGroup Venture Capital Minority
Dorm Room Fund Venture Capital Minority
Duro Ventures Venture Capital Minority
Endpoint Ventures Venture Capital Minority
First Round Capital Venture Capital Minority
You’re viewing 5 of 21 investors. Get the full list »

Ready to get started?

Request a free trial

Reverie Labs FAQs

  • When was Reverie Labs founded?

    Reverie Labs was founded in 2017.

  • Where is Reverie Labs headquartered?

    Reverie Labs is headquartered in Cambridge, MA.

  • What is the size of Reverie Labs?

    Reverie Labs has 13 total employees.

  • What industry is Reverie Labs in?

    Reverie Labs’s primary industry is Drug Discovery.

  • Is Reverie Labs a private or public company?

    Reverie Labs is a Private company.

  • What is the current valuation of Reverie Labs?

    The current valuation of Reverie Labs is .

  • What is Reverie Labs’s current revenue?

    The current revenue for Reverie Labs is .

  • How much funding has Reverie Labs raised over time?

    Reverie Labs has raised $31.6M.

  • Who are Reverie Labs’s investors?

    BoxGroup, Dorm Room Fund, Duro Ventures, Endpoint Ventures, and First Round Capital are 5 of 21 investors who have invested in Reverie Labs.

  • Who are Reverie Labs’s competitors?

    AROG Pharmaceuticals, Carna Biosciences, and NexImmune are competitors of Reverie Labs.

  • When was Reverie Labs acquired?

    Reverie Labs was acquired on 23-Feb-2024.

  • Who acquired Reverie Labs?

    Reverie Labs was acquired by Ginkgo Bioworks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »